Literature DB >> 15312802

The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol.

Aaron N A Verty1, Iain S McGregor, Paul E Mallet.   

Abstract

A large body of evidence supports the notion that Delta9-tetrahydrocannabinol (THC) stimulates food intake by its actions on CB1 cannabinoid receptors. Indirect evidence also suggests a role for dopamine (DA) receptors in mediating THC-induced feeding. In the present study, a series of experiments involving intraperitoneal drug administration in rats were conducted to further investigate the interaction between cannabinoid and dopamine receptors in feeding behaviour. Male Wistar rats were habituated to the test environment and injection procedure, and then were injected with vehicle alone, the dopamine D1-like receptor antagonist SCH 23390 (0.005, 0.01, 0.5 or 0.1 mg/kg), THC (0.1, 0.5 or 1.0 mg/kg) or SCH 23390 and THC combined. Food intake and locomotor activity were then measured for 120 min. Results revealed that administration of SCH 23390 dose-dependently decreased food intake while THC dose-dependently increased feeding. Furthermore, SCH 23390 attenuated feeding induced by THC at a dose that did not affect feeding on its own. These findings provide direct evidence for the existence of cannabinoid-dopamine interactions in feeding behaviour and suggest that dopamine D1 signalling is necessary for cannabinoids to stimulate food intake.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15312802     DOI: 10.1016/j.brainres.2004.06.033

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  A comparison of the effects of the CB(1) receptor antagonist SR141716A, pre-feeding and changed palatability on the microstructure of ingestive behaviour.

Authors:  Zoë D Thornton-Jones; Guy A Kennett; Steven P Vickers; Peter G Clifton
Journal:  Psychopharmacology (Berl)       Date:  2007-03-20       Impact factor: 4.530

Review 2.  The effects of Δ9-tetrahydrocannabinol on the dopamine system.

Authors:  Michael A P Bloomfield; Abhishekh H Ashok; Nora D Volkow; Oliver D Howes
Journal:  Nature       Date:  2016-11-17       Impact factor: 49.962

3.  Sound sequence discrimination learning motivated by reward requires dopaminergic D2 receptor activation in the rat auditory cortex.

Authors:  Masaharu Kudoh; Katsuei Shibuki
Journal:  Learn Mem       Date:  2006 Nov-Dec       Impact factor: 2.460

4.  The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia.

Authors:  Aaron N A Verty; Megan J Evetts; Geraldine J Crouch; Iain S McGregor; Aneta Stefanidis; Brian J Oldfield
Journal:  Neuropsychopharmacology       Date:  2011-03-16       Impact factor: 7.853

5.  Delta(9)-THC administered into the medial prefrontal cortex disrupts the spatial working memory.

Authors:  Lívia Carla Silva de Melo; Ariane Pinheiro Cruz; Saavedra José Rios Valentim; Andresa Rosane Marinho; Josidéia Barreto Mendonça; Ester Miyuki Nakamura-Palacios
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

6.  Effects of haloperidol on the delta-9-tetrahydrocannabinol response in humans: a responder analysis.

Authors:  Swapnil Gupta; Joao P De Aquino; Deepak C D'Souza; Mohini Ranganathan
Journal:  Psychopharmacology (Berl)       Date:  2019-03-27       Impact factor: 4.530

Review 7.  Cannabinoids in eating disorders and obesity.

Authors:  Francisco Arias Horcajadas
Journal:  Mol Neurobiol       Date:  2007-07-07       Impact factor: 5.590

8.  Delta-9-tetrahydrocannabinol enhances food reinforcement in a mouse operant conflict test.

Authors:  Maria Flavia Barbano; Anna Castañé; Elena Martín-García; Rafael Maldonado
Journal:  Psychopharmacology (Berl)       Date:  2009-05-19       Impact factor: 4.530

9.  Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus.

Authors:  François-Xavier Gamelin; Julien Aucouturier; Fabio Arturo Iannotti; Fabiana Piscitelli; Enrico Mazzarella; Teresa Aveta; Melissa Leriche; Erwan Dupont; Caroline Cieniewski-Bernard; Erwan Leclair; Bruno Bastide; Vincenzo Di Marzo; Elsa Heyman
Journal:  J Physiol Biochem       Date:  2017-03-10       Impact factor: 4.158

10.  Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.

Authors:  E L Nurmi; S L Spilman; F Whelan; L L Scahill; M G Aman; C J McDougle; L E Arnold; B Handen; C Johnson; D G Sukhodolsky; D J Posey; L Lecavalier; K A Stigler; L Ritz; E Tierney; B Vitiello; J T McCracken
Journal:  Transl Psychiatry       Date:  2013-06-25       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.